Literature DB >> 22802368

Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities.

Cindy V Josol1, Myrna Buenaluz-Sedurante, Mark Anthony Sandoval, Gerry Castillo.   

Abstract

A 55-year-old Filipina with Grave's disease, diabetes, hypertension, bronchial asthma, Parkinson's disease and a history of adverse drug reaction to penicillin consulted due to high-grade fever and sore throat. Patient was diagnosed with aplastic anaemia secondary to methimazole and was treated with high-dose granulocyte colony stimulating factor, thrombopoietin and mesterolone. Antibiotics used included levofloxacin, clindamycin, amikacin and fluconazole. Due to bleeding and slow recovery of blood parameters, 30 units of platelets and 7 units of packed red blood cells were transfused during her 22-day admission. This case presents a life-threatening adverse drug reaction in a patient with co-morbid conditions that complicate recovery and limit one's therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22802368      PMCID: PMC3029437          DOI: 10.1136/bcr.05.2010.2993

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Massive plasmocytosis due to methimazole-induced bone marrow toxicity.

Authors:  D V Breier; P Rendo; J Gonzalez; G Shilton; M Stivel; S Goldztein
Journal:  Am J Hematol       Date:  2001-08       Impact factor: 10.047

2.  Aplastic anemia secondary to methimazole-case report and review of hematologic side effects.

Authors:  S L Edell; D G Bartuska
Journal:  J Am Med Womens Assoc (1972)       Date:  1975-10

3.  Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes.

Authors:  J Piedras; G Hernández; X López-Karpovitch
Journal:  Am J Hematol       Date:  1998-02       Impact factor: 10.047

Review 4.  Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections.

Authors:  W H Sheng; C C Hung; Y C Chen; C T Fang; S M Hsieh; S C Chang; W C Hsieh
Journal:  QJM       Date:  1999-08

5.  [Methimazole-induced aplastic anemia].

Authors:  S Mechelli; S Bolognesi; E Siuti; A Stefanelli; M G Castiglioni
Journal:  Recenti Prog Med       Date:  1999-09

Review 6.  Aplastic anemia associated with antithyroid drugs.

Authors:  N Biswas; Y H Ahn; J M Goldman; J M Schwartz
Journal:  Am J Med Sci       Date:  1991-03       Impact factor: 2.378

7.  Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.

Authors:  Akemi Yamamoto; Yasuyuki Katayama; Koji Tomiyama; Hiroshi Hosoai; Fumihiko Hirata; Fumihiko Kimura; Kazuyuki Fujita; Hiroko Yasuda
Journal:  Thyroid       Date:  2004-03       Impact factor: 6.568

8.  Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.

Authors:  Junichi Tajiri; Shiro Noguchi
Journal:  Thyroid       Date:  2004-06       Impact factor: 6.568

9.  Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression.

Authors:  J Moreb; O Shemesh; S Shilo; C Manor; C Hershko
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

10.  Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.

Authors:  P Mezquita; V Luna; M Muñoz-Torres; E Torres-Vela; F Lopez-Rodriguez; J L Callejas; F Escobar-Jimenez
Journal:  Thyroid       Date:  1998-09       Impact factor: 6.568

View more
  1 in total

1.  Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics.

Authors:  Tania Sarker; Bülent Özgönenel; Manisha Gadgeel; Steven Buck; Amita Adhikari; Yaddanapudi Ravindranath
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-22       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.